[1] Libby P, Braunwald E.Braunwald’s heart disease : a textbook of cardiovascular medicine[M]. Philadelphia:Saunders/Elsevier, 2008. [2] Joner M, Finn AV, Farb A, et al.Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk[J]. J Am Coll Cardiol, 2006, 48(1):193-202. [3] Chatterjee S, Pandey A.Drug eluting stents: friend or foe? A review of cellular mechanisms behind the effects of Paclitaxel and sirolimus eluting stents[J]. Curr Drug Metab, 2008, 9(6):554-566. [4] Polimeni A, De Rosa S, Indolfi C.Vascular miRNAs after balloon angioplasty[J]. Trends Cardiovasc Med, 2013, 23:9-14. [5] Curcio A, Torella D, Indolfi C.Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy[J]. Circ J, 2011, 75(6):1287-1296. [6] Lowe HC, Oesterle SN, Khachigian LM.Coronary in-stent restenosis: current status and future strategies[J]. J Am Coll Cardiol, 2002, 39(2):183-193. [7] Kamura T, Hara T, Matsumoto M, et al.Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase[J]. Nat Cell Biol, 2004, 6(12):1229-1235. [8] Kravtsova-Ivantsiv Y, Shomer I, Cohen-Kaplan V, et al.KPC1-mediated ubiquitination and proteasomal processing of NF-kappaB1 p105 to p50 restricts tumor growth[J]. Cell,2015, 161(2):333-347. [9] Wang JN, Shi N, Xie WB, et al.Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration[J]. Arterioscler Thromb Vasc Biol, 2011, 31(8):e19-e26. [10] 杨波, 吴冰, 唐俊明, 等. 大鼠颈总动脉球囊拉伤所致血管狭窄模型的建立[J]. 实验动物与比较医学, 2015, 35(2):87-91. [11] Gruntzig A.Transluminal dilatation of coronary-artery stenosis[J]. Lancet, 1978, 1(8058):263. [12] Muzina A, Wei L.Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns of in-stent restenosis among bare metal stents and drug eluting stents[J]. J Thorac Dis, 2016, 8(1):E104-E108. [13] Forrester JS, Fishbein M, Helfant R, et al.A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies[J]. J Am Coll Cardiol, 1991, 17(3):758-769. [14] Costa MA, Simon DI.Molecular basis of restenosis and drug-eluting stents[J]. Circulation, 2005, 111(17):2257-2273. [15] Wang JN, Shi N, Chen SY.Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells[J]. Free Radic Biol Med, 2012, 52(1):173-181. [16] Teyssier J R, Rey R, Ragot S, et al.Correlative gene expression pattern linking RNF123 to cellular stress-senescence genes in patients with depressive disorder: implication of DRD1 in the cerebral cortex[J]. J Affect Disord, 2013, 151(2):432-438. [17] Lu C, Huang X, Zhang X, et al.miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1[J]. Blood, 2011, 117(16):4293-4303. [18] Hristova NR, Tagscherer KE, Fassl A, et al.Notch1-dependent regulation of p27 determines cell fate in colorectal cancer[J]. Int J Oncol, 2013, 43(6):1967-1975. [19] 景彩萍. NF-κB抑制剂对乳腺癌细胞增殖作用的影响及P65、MMP-9蛋白表达研究[D]. 延安: 延安大学, 2015. [20] Siggers T, Chang AB, Teixeira A, et al.Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding[J]. Nat Immunol, 2012, 13(1):95-102. [21] 杨春妮,杨一兵. NF-κB及其信号传导通路与肿瘤放射耐受的研究进展[J]. 中国现代医药杂志, 2015(12):106-109. |